MiR-328–3p inhibits lung adenocarcinoma-genesis by downregulation PYCR1
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-328–3p inhibits lung adenocarcinoma-genesis by downregulation PYCR1
Authors
Keywords
miR-328–3p, PYCR1, Lung adenocarcinoma, Proliferation, Apoptosis, Migration
Journal
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume 550, Issue -, Pages 99-106
Publisher
Elsevier BV
Online
2021-03-09
DOI
10.1016/j.bbrc.2021.02.029
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-328-3p inhibits cell proliferation and metastasis in colorectal cancer by targeting Girdin and inhibiting the PI3K/Akt signaling pathway
- (2020) Shuang Pan et al. EXPERIMENTAL CELL RESEARCH
- PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma
- (2020) Yawen Gao et al. MOLECULAR CARCINOGENESIS
- miR-328-3p overexpression attenuates the malignant proliferation and invasion of liver cancer via targeting Endoplasmic Reticulum Metallo Protease 1 to inhibit AKT phosphorylation
- (2020) Hua Lu et al. Annals of Translational Medicine
- Inhibition of miR-328-3p impairs cancer stem cell function and prevents metastasis in ovarian cancer
- (2019) Amit K Srivastava et al. CANCER RESEARCH
- Pyrroline-5-Carboxylate Reductase 1 Accelerates the Migration and Invasion of Nonsmall Cell Lung Cancer In Vitro
- (2019) Senhua Sang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- P5CR1 protein expression and the effect of gene-silencing on lung adenocarcinoma
- (2019) Yang She et al. PeerJ
- Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p
- (2019) Bin Xiao et al. BMC CANCER
- PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer
- (2019) Juhua Zhuang et al. Journal of Translational Medicine
- MiR‐195 and miR‐497 suppress tumorigenesis in lung cancer by inhibiting SMURF2‐induced TGF‐β receptor I ubiquitination
- (2019) Dong‐Kyu Chae et al. Molecular Oncology
- Knockdown of PYCR1 inhibits proliferation, drug resistance and EMT in colorectal cancer cells by regulating STAT3-Mediated p38 MAPK and NF-κB signalling pathway
- (2019) Kun Yan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PYCR1 promotes the progression of non-small-cell lung cancer under the negative regulation of miR-488
- (2018) Dongchang Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Knockdown of PYCR1 inhibits cell proliferation and colony formation via cell cycle arrest and apoptosis in prostate cancer
- (2017) Tengyue Zeng et al. MEDICAL ONCOLOGY
- Intersecting transcriptomic profiling technologies and long non-coding RNA function in lung adenocarcinoma: discovery, mechanisms, and therapeutic applications
- (2017) Jonathan Castillo et al. Oncotarget
- Up- regulation of miR-328-3p sensitizes non-small cell lung cancer to radiotherapy
- (2016) Wei Ma et al. Scientific Reports
- miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells
- (2015) Xue-tao Li et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer
- (2015) Petra Leidinger et al. Oncotarget
- MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship
- (2012) Amy E. Pasquinelli NATURE REVIEWS GENETICS
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started